The Boehringer Ingelheim Venture Fund is committed to advancing scientific innovation by investing in first-in-class, disease-modifying therapeutics across various modalities. Since its inception, the fund has invested in numerous companies focused on groundbreaking therapeutic approaches and technologies.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions